Global Poultry Food Animal Eubiotic Market Report 2026-2036

Executive Summary

The global Poultry Food Animal Eubiotic market is a rapidly evolving and strategically important segment within the animal health and nutrition industry. Eubiotics, which encompass probiotics, prebiotics, organic acids, and essential oils, are alternatives to antibiotic growth promoters (AGPs), used to maintain gut health, enhance nutrient absorption, and improve overall poultry performance. This report provides a comprehensive analysis of the industry from 2026 to 2036, highlighting the global shift towards sustainable poultry production, the phase-out of antibiotic growth promoters worldwide, and the increasing consumer demand for antibiotic-free poultry products.

1. Market Overview

The global Poultry Food Animal Eubiotic market was valued at approximately USD 1.85 Billion in 2025 and is expected to reach approximately USD 3.15 Billion by the year 2036, growing at a Compound Annual Growth Rate (CAGR) of 5.0% globally during the forecast period.

Eubiotics are feed additives that improve the microbial balance in the animal's gastrointestinal tract. By promoting beneficial bacteria and inhibiting pathogens, they enhance digestion, boost immunity, and improve feed conversion ratios (FCR). The term "eubiotic" is derived from "eu" (good) and "biotic" (life), reflecting their role in fostering a healthy gut ecosystem. The market is primarily driven by the global regulatory crackdown on antibiotic use in animal feed and the rising consumer preference for antibiotic-free poultry products.

Impact of COVID-19 on Poultry Food Animal Eubiotic Market

The COVID-19 pandemic had a mixed impact on the poultry eubiotic market. In 2020, disruptions in the food service industry and supply chain bottlenecks affected poultry production in some regions. However, the pandemic also heightened global awareness of food security and the importance of animal health. The essential nature of the poultry industry to feed populations ensured continued demand. Furthermore, the pandemic reinforced the need to reduce antibiotic use to combat antimicrobial resistance, a long-term driver for eubiotics. The market demonstrated resilience and recovered steadily as poultry production normalized globally.

2. Market Segmentation Analysis

By Type (Eubiotic Category)

• Probiotics: The largest segment, consisting of live beneficial microorganisms (bacteria or yeasts) that colonize the gut and improve its microbial balance. Common strains include Lactobacillus, Bifidobacterium, Bacillus subtilis, Enterococcus, and Saccharomyces cerevisiae. They compete with pathogens, produce antimicrobial compounds, and enhance immune function.

• Prebiotics: Non-digestible feed ingredients that selectively stimulate the growth and activity of beneficial gut bacteria. Common prebiotics include:

  • Mannan-oligosaccharides (MOS): Derived from yeast cell walls, bind to pathogens and prevent their colonization.

  • Fructo-oligosaccharides (FOS): Fermented by beneficial bacteria, promoting their growth.

  • Galacto-oligosaccharides (GOS): Support beneficial gut flora.

• Organic Acids: Acidifiers that lower the pH of the gut, creating an unfavorable environment for pathogens like Salmonella and E. coli. They also improve nutrient digestibility. Common acids include formic acid, propionic acid, citric acid, lactic acid, and their salts (e.g., calcium propionate).

• Essential Oils (Phytogenics): Plant-derived compounds with antimicrobial, anti-inflammatory, and antioxidant properties. Common essential oils include thymol (from thyme), carvacrol (from oregano), cinnamaldehyde (from cinnamon), and eugenol (from clove). They enhance gut health and overall performance.

• Synbiotics: A synergistic combination of probiotics and prebiotics designed to work together for enhanced efficacy. This is an emerging high-growth segment.

By Application (Poultry Category)

• Broilers (Cubs Chicken / Meat-type Chickens): The dominant application segment, representing over 60% of market share. Eubiotics are used in broiler feed to:

  • Improve feed conversion ratio (FCR) and weight gain.

  • Reduce mortality and morbidity from enteric diseases (e.g., necrotic enteritis).

  • Enhance carcass quality and meat safety.

  • Ensure production of antibiotic-free (ABF) or "raised without antibiotics" (RWA) poultry.

• Layers (Adult Chicken / Egg-type Chickens): A significant and growing segment. Eubiotics are used in layer feed to:

  • Improve egg production rates and egg quality (shell strength, yolk color).

  • Extend the peak laying period.

  • Enhance gut health and nutrient absorption.

  • Reduce the risk of Salmonella contamination in eggs.

• Breeders (Parent Stock): A smaller but critical segment focused on maintaining the health and fertility of breeding flocks, ensuring healthy offspring.

• Turkeys & Other Poultry: Includes turkeys, ducks, geese, and other poultry species, with growing adoption of eubiotic solutions.

By Form

• Dry (Powder/Granules): The most common form, easy to mix into feed formulations. Offers longer shelf life and stability.

• Liquid: Used in drinking water application, particularly during stress periods (e.g., post-vaccination, during transport) or for young chicks that may not be eating solid feed.

3. Regional Analysis

• Asia-Pacific: The largest and fastest-growing market, driven by massive poultry production to meet rising protein demand.

  • China: The world's largest poultry producer and a major consumer of eubiotics. The government's ban on AGPs in feed has been a massive market driver.

  • India: A high-growth market with a rapidly expanding poultry sector and increasing awareness of antibiotic-free production.

  • Southeast Asia: Countries like Thailand, Vietnam, and Indonesia are major poultry producers with growing adoption of modern animal husbandry practices.

  • Japan & South Korea: Mature markets with stringent food safety regulations and high demand for premium, safe poultry products.

• Europe: A mature and highly regulated market, leading the global shift away from AGPs. The EU ban on antibiotic growth promoters since 2006 has made eubiotics standard practice. Germany, France, Spain, and the UK are key markets. Strong focus on sustainability and reducing antimicrobial resistance.

• North America: A large and established market with growing adoption of antibiotic-free (ABF) and "no antibiotics ever" (NAE) production systems, particularly in the U.S. Major poultry integrators are driving demand for effective eubiotic solutions to maintain flock health without antibiotics.

• South America: A significant poultry-producing region (Brazil is a top global exporter). Demand for eubiotics is growing to meet both domestic food safety standards and the requirements of export markets (especially Europe and Asia).

• Middle East & Africa: An emerging market with increasing poultry production to ensure food security. Adoption of eubiotics is growing, driven by import requirements from major trading partners and local food safety initiatives.

4. Key Players & Competitive Landscape

The market is highly competitive, featuring a mix of global animal health and nutrition giants, specialized biotechnology companies, and regional feed additive manufacturers. Competition is based on product efficacy, strain specificity (for probiotics), formulation technology, regulatory approval, and scientific support.

Expanded List of Key Players:

Global Leaders:

1. Royal DSM (Netherlands): A global leader in health, nutrition, and bioscience, offering a comprehensive portfolio of eubiotic solutions, including probiotics and organic acids.

2. BASF SE (Germany): A global chemical giant with a strong animal nutrition division, offering organic acids, essential oils, and enzyme-based solutions.

3. Cargill, Incorporated (USA): A major player in animal nutrition, providing a wide range of eubiotic feed additives and nutritional solutions.

4. DuPont de Nemours, Inc. (USA): A leader in probiotics and microbial solutions (now part of IFF's Health & Biosciences division), with strong scientific backing for its strains.

5. Chr. Hansen Holding A/S (Denmark): A global leader in microbial solutions, offering high-quality probiotic strains specifically developed for animal health.

6. Kemin Industries, Inc. (USA): A privately-held global manufacturer specializing in ingredients for human and animal health, with a strong portfolio of eubiotics, including essential oils and organic acids.

7. Novus International, Inc. (USA): A leader in animal health and nutrition, offering organic acid-based solutions and specialty ingredients.

8. ADDCON GmbH (Germany): A specialist in organic acid-based feed additives and preservatives.

9. Yara International ASA (Norway): A global leader in crop nutrition and industrial solutions, with a presence in organic acids for feed preservation.

10. Behn Meyer (Germany/Malaysia): A leading distributor and manufacturer of chemicals and feed additives in Asia-Pacific.

11. Beneo Group (Germany): A leader in prebiotic ingredients (inulin, oligofructose) derived from chicory roots for animal and human nutrition.

12. Lallemand Inc. (Canada): A global leader in yeast and bacteria-based fermentation solutions, offering probiotics and yeast derivatives for animal feed.

Regional & Emerging Players:
13. Qingdao Vland Biotech Group (China): A major Chinese biotechnology company with a strong portfolio of probiotics and enzymes.
14. Baolai Leelai Group (China): A leading Chinese manufacturer of feed additives, including probiotics and organic acids.
15. Guangzhou Xipu (China): A Chinese animal health company specializing in eubiotic solutions.
16. Guangzhou Juntai (China): A Chinese manufacturer of feed additives and nutritional products.
17. Lucky Yinthai (China): A Chinese supplier of animal feed ingredients.
18. Shanghai Zzfeed (China): A Chinese animal nutrition company.
19. Greencore (India): An Indian manufacturer of feed additives and nutritional supplements.
20. Protexin (ADM Protexin) (UK): A leading probiotic manufacturer (now part of ADM) with a strong presence in the animal health market.

5. Strategic Analysis Frameworks

Porter's Five Forces Analysis

• Threat of New Entrants (Medium): Scientific expertise in microbiology and formulation, along with regulatory approvals, create barriers. However, regional players can enter with single products.

• Bargaining Power of Buyers (High): Large poultry integrators purchase in massive volumes and can negotiate aggressively on price and demand proven efficacy.

• Bargaining Power of Suppliers (Medium): Suppliers of raw materials (e.g., specific bacterial strains, organic acids, plant extracts) have moderate leverage. Large players often have proprietary strains.

• Threat of Substitutes (Medium): Traditional antibiotics are being phased out. Other gut health management tools include enzymes, zinc oxide, and improved farm management practices.

• Intensity of Rivalry (High): Intense competition between global giants and regional players, with differentiation based on scientific data, product combinations, and on-farm technical support.

SWOT Analysis

• Strengths:

  • Addresses the global need for sustainable, antibiotic-free poultry production.

  • Improves feed efficiency and bird performance, directly impacting producer profitability.

  • Enhances food safety by reducing pathogen load (Salmonella, Campylobacter).

  • Aligns with consumer demand for natural and safe food.

• Weaknesses:

  • Efficacy can be variable and dependent on farm management, bird health status, and diet.

  • Higher cost compared to traditional antibiotics in some markets.

  • Requires technical expertise for proper selection and application.

  • Probiotics require careful handling to maintain viability.

• Opportunities:

  • Regulatory Bans on AGPs: Ongoing and future bans in new regions create market expansion opportunities.

  • Synbiotics: Growing interest in combining probiotics and prebiotics for enhanced efficacy.

  • Precision Nutrition: Development of targeted eubiotic solutions based on the bird's age, genetics, and health status.

  • Emerging Markets: Rapidly growing poultry sectors in Asia, Africa, and Latin America.

• Threats:

  • Economic Downturns: High feed costs and market volatility can lead producers to reduce additive usage.

  • Disease Outbreaks: Avian influenza outbreaks can decimate flocks and disrupt demand.

  • Regulatory Hurdles: Varying and sometimes unclear regulations for eubiotic approval across different countries.

  • Greenwashing/Skepticism: Concerns about exaggerated claims and lack of consistent scientific validation.

6. Market Dynamics

Drivers

1. Ban on Antibiotic Growth Promoters (AGPs): The single most significant driver, with regions worldwide (EU, USA, China, etc.) implementing restrictions or bans on AGP use.

2. Consumer Demand for Antibiotic-Free Poultry: Growing consumer awareness and preference for "raised without antibiotics" (RWA) or "no antibiotics ever" (NAE) chicken.

3. Rising Global Protein Demand: Increasing global population and middle class, particularly in Asia, drive demand for poultry meat and eggs, necessitating efficient and sustainable production.

4. Focus on Food Safety: Eubiotics help reduce foodborne pathogens like Salmonella and Campylobacter in poultry products, meeting retailer and consumer safety requirements.

5. Improved Feed Efficiency: Eubiotics enhance nutrient absorption, improving feed conversion ratios (FCR) and reducing the cost per kilogram of meat or dozen of eggs.

Challenges

1. Variable Efficacy: The performance of eubiotics can be inconsistent, depending on farm conditions, biosecurity, bird health, and diet composition.

2. Higher Cost: Eubiotics are often more expensive than the antibiotics they replace, impacting producer margins.

3. Need for Technical Expertise: Effective use requires understanding of gut health, microbiology, and nutrition, necessitating trained personnel and technical support.

4. Complex Regulatory Landscape: Navigating the approval and registration process for eubiotics in different countries is time-consuming and costly.

7. Trend Analysis

• Shift Towards Synbiotics: Increasing interest in combining scientifically matched probiotics and prebiotics for a synergistic effect that is greater than the sum of its parts.

• Strain-Specific Probiotics: A move away from generic probiotics towards strains with documented, specific benefits (e.g., a Bacillus strain proven to reduce Salmonella or a Lactobacillus strain that boosts egg production).

• Butyrate and its Derivatives: Growing use of butyric acid (and its protected forms) as a key organic acid for gut health, as it serves as a primary energy source for gut cells.

• Essential Oil Blends: Formulation of proprietary blends of multiple essential oils to target different pathogens and provide synergistic benefits (e.g., thymol + carvacrol).

• Protected/Encapsulated Technologies: Development of encapsulation technologies to protect probiotics and sensitive organic acids from the harsh conditions of the upper gastrointestinal tract, ensuring they reach the lower gut where they are most effective.

• Data-Driven Nutrition: Integration of eubiotic strategies into precision nutrition models, using data on bird health, performance, and gut microbiome analysis to tailor feed additive programs.

8. Value Chain Analysis

1. Upstream (Raw Material Sourcing):

   • Probiotics: Sourcing of specific bacterial strains from culture collections, fermentation substrates.

   • Prebiotics: Sourcing of chicory roots (for inulin), yeast (for MOS).

   • Organic Acids: Petrochemical or fermentation-based production.

   • Essential Oils: Sourcing of plant materials (oregano, thyme, cinnamon) from agricultural producers.

2. Midstream (Manufacturing & Formulation):

   • Fermentation (for probiotics), extraction (for essential oils), chemical synthesis (for organic acids).

   • Formulation into stable, effective products with appropriate carriers and protection technologies.

   • Quality control and potency testing.

3. Downstream (Distribution & Feed Integration):

   • Distribution to feed mills or integrators.

   • Incorporation into poultry feed at specified inclusion rates.

   • On-farm application via water (liquid forms).

4. End-Use (Poultry Production):

   • Broiler, layer, and breeder farms.

   • Production of meat and eggs for human consumption.

9. Quick Recommendations for Stakeholders

• For Manufacturers:

  • Invest in Science and Validation: Differentiate products through robust, peer-reviewed research demonstrating specific, consistent benefits under commercial conditions.

  • Develop Synbiotic Solutions: Invest in R&D to create proprietary, scientifically validated synbiotic combinations that offer superior efficacy.

  • Provide On-Farm Technical Support: Employ nutritionists and veterinarians to help customers implement eubiotic programs effectively and troubleshoot issues.

  • Explore Encapsulation Technologies: Invest in advanced delivery systems to enhance the stability and efficacy of sensitive ingredients.

• For Investors:

  • Target Companies with Strong IP: Favor companies with proprietary probiotic strains, unique formulations, and patents on specific combinations.

  • Focus on Integrated Players: Companies that can offer a full portfolio (probiotics, prebiotics, organic acids, essential oils) are better positioned to meet diverse customer needs.

  • Assess Regulatory Expertise: Evaluate a company's ability to navigate complex global regulatory approvals.

• For Poultry Producers/Integrators:

  • Adopt a Holistic Gut Health Program: Eubiotics are most effective when combined with good biosecurity, optimal nutrition, and proper farm management. They are not a standalone magic bullet.

  • Trial Products Rigorously: Conduct on-farm trials to evaluate the efficacy of different products under your specific conditions before large-scale adoption.

  • Partner with Suppliers: Work closely with eubiotic suppliers for technical support and to design customized programs for your flocks.

  • Train Farm Staff: Ensure farm managers and staff understand the importance of gut health and the proper use of eubiotic products.